State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF is a ETF series of SPDR SERIES TRUST (series S000012321). Net assets $307.9M as of 2026-03-31. Index fund.
Showing 15 of 62 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| State Street Global Advisors | — | $24.4M | 792.58% |
| Enliven Therapeutics Inc | — | $7.5M | 244.85% |
| Corcept Therapeutics Inc | — | $7.1M | 229.10% |
| Terns Pharmaceuticals Inc | — | $6.7M | 216.10% |
| Perrigo Co PLC | — | $6.5M | 209.93% |
| Axsome Therapeutics Inc | — | $6.3M | 203.20% |
| Innoviva Inc | — | $6.1M | 199.28% |
| Merck & Co Inc | — | $6.1M | 198.49% |
| Pfizer Inc | — | $6.1M | 197.24% |
| Royalty Pharma PLC | — | $6.1M | 197.01% |
| Elanco Animal Health Inc | — | $6.0M | 195.68% |
| Jazz Pharmaceuticals PLC | — | $6.0M | 195.51% |
| Esperion Therapeutics Inc | — | $6.0M | 195.34% |
| Edgewise Therapeutics Inc | — | $6.0M | 194.91% |
| MBX Biosciences Inc | — | $6.0M | 194.64% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $307.9M |
| 2025-12-31 | $230.0M |
| 2025-09-30 | $175.2M |
| 2025-06-30 | $148.0M |
| 2025-03-31 | $162.3M |
| 2024-12-31 | $159.3M |
| 2024-09-30 | $186.5M |
| 2024-06-30 | $195.1M |